Home/ Supplements/ Vitamin K/ Vitamin K2 50 mcg

Vitamin K2 50 mcg

product on market Softgel Capsule Vitacost Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is associated with supporting bone health and cardiovascular function by regulating calcium deposition. There is moderate research evidence suggesting it helps direct calcium into the bone matrix and away from arterial walls. This specific formulation provides a low dose of 50 mcg.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 50 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
30
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mcg (63% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Sunflower seed Oil Gelatin Glycerin Water natural Caramel color Titanium Dioxide
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions As a dietary supplement for adults 18 years of age and over, take 1 softgel daily or as directed by a healthcare professional.

Warnings & Precautions

Warnings Pregnant or lactating women, diabetics, hypoglycemics and people with known medical conditions and/or taking drugs should consult with a licensed physician and/or pharmacist prior to taking dietary supplements.

Warnings Pregnant or lactating women, diabetics, hypoglycemics and people with known medical conditions and/or taking drugs should consult with a licensed physician and/or pharmacist prior to taking dietary supplements. Individuals taking anticoagulants (e.g., warfarin, heparin) or aspirin and other salicylates should consult with their physician before taking supplemtents containing vitamin K.

Keep out of reach of children.

Contains: Soy.

Formulation Notes

Free of Milk, eggs, peanuts, crustacean shellfish, fish, gluten.

Vitacost Vitamin K2 - MenaQ7 description Natural vitamin K2 supplement for bone health support. Featuring MenaQ7 - a premium, clinically studied form of vitamin K2.

With MenaQ7 - a clinically studied form of vitamin K2

Features clinically studied MenaQ7 natural vitamin K2

Contains: Soy.

Additional Information

Keep dry and at room temperature (59(0)-75(0)F [15(0)-24(0)C]).

Natural bone health support

Naturally derived from Japanese natto (fermented soybeans) Superior to K2 supplements made with the synthetic (MK-4) form Supplies 50 mcg per serving

What is Vitamin K? Vitamin K is a group of compounds known as quinones, needed by the body to make certain types of proteins required for normal blood coagulation and bone health. Vitamin K1 (phylloquinone) is found primarily in leafy green vegetables such as spinach and kale, while vitamin K2 (menaquinone) is produced by bacteria in both human and animal intestines.

How does Vitamin K support health? Vitamin K's primary function in the body is to aid in the production of Gla (gamma carboxyglutamic acid) proteins, which play a part in coagulation and anti-coagulation of blood. Vitamin K is also necessary for osteoblasts (bone-forming cells) to activate osteocalcin, a protein that binds calcium to bones. Therefore, adequate amounts of vitamin K make certain calcium is properly delivered to bones and arterial health is maintained.

Why choose Vitacost Vitamin K?

Derived from the Japanese food natto, not synthetically made. 50 mcg per single-softgel serving 30 serving per bottle Incredible quality at an everyday low, affordable price

About Vitacost Vitacost nutritional products are manufactured to high standards of quality, efficacy and saftey. Each Vitacost product meets or exceeds the standards and requirements set forth in the FDA's code or Federal Regulation (21 CFR, 111) Current Good Manufacturing Practices (cGMP).

Metadata

Product Details

UPC / SKU8 44197 01939 7
DSLD Entry Date2017-01-25
Product TypeVitamin
FormSoftgel Capsule
DSLD ID70231
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.